​

McKesson (MCK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MCK Stock Forecast

McKesson (MCK) stock forecast, based on 31 Wall Street analysts, predicts a 12-month average price target of $994.86, with a high of $1,085.00 and a low of $875.00. This represents a 26.38% increase from the last price of $787.19.

$450 $580 $710 $840 $970 $1 High: $1085 Avg: $994.86 Low: $875 Last Closed Price: $787.19

MCK Stock Rating

McKesson stock's rating consensus is Buy, based on 31 Wall Street analysts. The breakdown includes 1 Strong Buy (3.23%), 24 Buy (77.42%), 6 Hold (19.35%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 31 6 24 1 Strong Sell Sell Hold Buy Strong Buy

MCK Price Target Upside V Benchmarks

TypeNameUpside
StockMcKesson26.38%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks23.14%

Price Target Trends

1M3M12M
# Anlaysts-212
Avg Price Target-$962.50$959.67
Last Closing Price$787.19$787.19$787.19
Upside/Downside-22.27%21.91%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 264112--17
May, 263113--17
Apr, 263104--17
Mar, 263103-117
Feb, 263103-117
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 08, 2026Kevin CaliendoUBS$1.05K$744.4641.04%33.39%
May 08, 2026George HillDeutsche Bank$875.00$763.9014.54%11.15%
Mar 05, 2026Raymond James$970.00$930.314.27%23.22%
Mar 05, 2026Michael ChernyLeerink Partners$1.08K$930.2216.64%37.83%
Feb 18, 2026Barclays$1.05K$946.4710.94%33.39%
Jan 29, 2026Morgan Stanley$966.00$826.6216.86%22.71%
Jan 14, 2026Eric ColdwellRobert W. Baird$968.00$833.3616.16%22.97%
Dec 08, 2025Barclays$960.00$797.9320.31%21.95%
Nov 06, 2025Evercore ISI$1.00K$852.0217.37%27.03%
Oct 27, 2025Kevin CaliendoUBS$920.00$801.3014.81%16.87%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 08, 2026UBSBuyBuyhold
May 08, 2026Deutsche BankBuyBuyhold
Apr 28, 2026William BlairOutperforminitialise
Mar 05, 2026Bank of America SecuritiesBuyBuyhold
Mar 05, 2026Leerink PartnersOutperformOutperformhold
Mar 05, 2026Evercore ISIOutperformOutperformhold
Feb 18, 2026BarclaysOverweightOverweighthold
Feb 05, 2026Cowen & Co.BuyBuyhold
Jan 29, 2026Morgan StanleyOverweightOverweighthold
Dec 22, 2025Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

$5 $16 $27 $38 $49 $60 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$7.31$25.23$22.54$25.86$38.55---
Avg Forecast$23.89$25.96$27.61$32.69$36.82$41.28$46.94$53.78
High Forecast$24.51$26.88$27.95$32.97$37.67$43.85$48.61$55.70
Low Forecast$23.20$25.16$27.47$32.40$35.56$35.30$45.51$52.14
Surprise %-69.40%-2.81%-18.36%-20.89%4.70%---

Revenue Forecast

$250B $310B $370B $430B $490B $550B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$263.97B$276.71B$308.95B$359.05B$403.43B---
Avg Forecast$260.88B$275.91B$311.92B$360.18B$396.03B$424.30B$464.80B$517.85B
High Forecast$266.13B$283.48B$312.88B$362.60B$412.08B$425.21B$477.55B$532.05B
Low Forecast$255.12B$269.43B$309.58B$357.80B$382.12B$423.39B$453.88B$505.68B
Surprise %1.18%0.29%-0.95%-0.31%1.87%---

Net Income Forecast

$500M $2B $3B $5B $6B $8B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$1.11B$3.56B$3.00B$3.29B$4.76B---
Avg Forecast$1.15B$3.48B$3.00B$4.38B$4.91B$5.31B$6.29B$7.21B
High Forecast$1.39B$3.60B$3.60B$4.42B$5.05B$5.88B$6.52B$7.47B
Low Forecast$919.44M$3.37B$2.39B$4.34B$4.77B$4.73B$6.10B$6.99B
Surprise %-3.33%2.28%0.13%-24.81%-3.00%---

MCK Forecast FAQ

Is McKesson stock a buy?

McKesson stock has a consensus rating of Buy, based on 31 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 24 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that McKesson is a favorable investment for most analysts.

What is McKesson's price target?

McKesson's price target, set by 31 Wall Street analysts, averages $994.86 over the next 12 months. The price target range spans from $875 at the low end to $1.08K at the high end, suggesting a potential 26.38% change from the previous closing price of $787.19.

How does McKesson stock forecast compare to its benchmarks?

McKesson's stock forecast shows a 26.38% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical distribution stocks industry (23.14%).

What is the breakdown of analyst ratings for McKesson over the past three months?

  • June 2026: 23.53% Strong Buy, 64.71% Buy, 11.76% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 17.65% Strong Buy, 64.71% Buy, 17.65% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 17.65% Strong Buy, 58.82% Buy, 23.53% Hold, 0% Sell, 0% Strong Sell.

What is McKesson’s EPS forecast?

McKesson's average annual EPS forecast for its fiscal year ending in March 2027 is $41.28, marking a 7.08% increase from the reported $38.55 in 2026. Estimates for the following years are $46.94 in 2028, and $53.78 in 2029.

What is McKesson’s revenue forecast?

McKesson's average annual revenue forecast for its fiscal year ending in March 2027 is $424.3B, reflecting a 5.17% increase from the reported $403.43B in 2026. The forecast for 2028 is $464.8B, and $517.85B for 2029.

What is McKesson’s net income forecast?

McKesson's net income forecast for the fiscal year ending in March 2027 stands at $5.31B, representing an 11.45% increase from the reported $4.76B in 2026. Projections indicate $6.29B in 2028, and $7.21B in 2029.